About Us
About Noramco
Our People
Leadership
Excellence in Compliance
Minimizing Risk
Products & Solutions
Active Pharmaceutical Ingredients
Active Pharmaceutical Ingredients
Nal Family of Antagonists
ADHD / Stimulants
Full Product List
Noramco Solutions
Noramco Solutions
Clinical Supply
Controlled Substance Building Blocks and Intermediates
Platform Technologies
Platform Technologies
Platform Technology: Custom Synthesis
Reference Standards
Reference Standards
Reference Standards: Custom Synthesis
Reference Standards Store
Careers
News & Events
News & Events
Press Releases
Contact
spi-press
Home
Noramco and SPI Pharma sign letter of intent to develop formulation solution packages
spi-press
spi-press
Author
Michael McDonald
Posted on
October 26, 2017
0
Previous Post
Noramco and SPI Pharma sign letter of intent to develop formulation solution packages